Related Experiment Video
Updated: Sep 15, 2025

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
Common bile duct dilatation on MRI in autosomal dominant polycystic kidney disease
Usama Sattar1, Chenglin Zhu1, Xiaorui Yin1
1Weill Cornell Medicine, New York, USA.
Purpose:
Polycystic liver disease is the most prevalent extrarenal manifestation of autosomal dominant polycystic kidney disease (ADPKD). Non-obstructive asymptomatic common bile duct (CBD) dilatation has been observed anecdotally on CT scans, but CT is not optimal for biliary visualization. Here, we measured CBD diameter on T2-weighted MRI in ADPKD subjects to determine if CBD dilatation is associated with ADPKD.
Methods:
CBD diameter was measured retrospectively on ADPKD subjects (n = 254) and on age- and sex-matched controls without ADPKD (n = 254) who underwent abdominal MRI. CBD diameter in these groups was compared and correlated with clinical, laboratory and magnetic resonance imaging (MRI) features, including organ volumes and cyst burden.
Results:
CBD median diameter [interquartile range, IQR, 25%, 75%] was 22% larger in ADPKD compared to controls (5.6 [4.7, 6.9] mm vs. 4.6 [3.9, 5.4] mm, p < 0.001). CBD diameter measurements had excellent inter-observer agreement (Intraclass correlation coefficient = 0.92). Thirteen (5.1%) ADPKD subjects had a CBD diameter ≥ 10 mm compared to 1 (0.4%) control subject (p < 0.001). Multivariable analysis found the presence of PKD1 or PKD2 mutation (beta = 1.5, P < 0.001) and age (beta = 0.04, p < 0.001) to be associated with increased CBD diameter and serum albumin associated with decreased CBD diameter (beta=-0.39, p < 0.001).
Conclusion:
ADPKD subjects had 22% larger CBD diameters than in non-ADPKD controls and were more likely to have CBD dilatation ≥ 10 mm without CBD obstruction. Awareness of this association of non-obstructive CBD dilatation with ADPKD may limit unnecessary diagnostic testing.
Insights
Autosomal dominant polycystic kidney disease (ADPKD) is linked to larger common bile duct (CBD) diameters. This finding in ADPKD patients may help reduce unnecessary diagnostic tests for non-obstructive CBD dilatation.
Area of Science:
- Hepatology
- Radiology
- Genetics
Background:
- Polycystic liver disease is a common manifestation of autosomal dominant polycystic kidney disease (ADPKD).
- Common bile duct (CBD) dilatation has been anecdotally observed in ADPKD but not systematically studied due to limitations of CT scans for biliary visualization.
Purpose of the Study:
- To measure CBD diameter using T2-weighted MRI in ADPKD subjects.
- To determine if CBD dilatation is associated with ADPKD.
Main Methods:
- Retrospective measurement of CBD diameter on T2-weighted MRI scans.
- Comparison of CBD diameter between 254 ADPKD subjects and 254 age- and sex-matched controls.
- Correlation of CBD diameter with clinical, laboratory, and MRI features, including organ volumes and cyst burden.
Main Results:
- ADPKD subjects exhibited a 22% larger median CBD diameter (5.6 mm) compared to controls (4.6 mm) (p < 0.001).
- A significantly higher proportion of ADPKD subjects (5.1%) had CBD diameter ≥ 10 mm versus controls (0.4%) (p < 0.001).
- Multivariable analysis indicated PKD1/PKD2 mutation presence and age were associated with increased CBD diameter, while serum albumin was associated with decreased diameter.
Conclusions:
- ADPKD is associated with significantly larger CBD diameters and a higher likelihood of non-obstructive CBD dilatation (≥ 10 mm).
- Awareness of this association may help clinicians avoid unnecessary diagnostic procedures in ADPKD patients.
- T2-weighted MRI is an effective tool for assessing CBD diameter in ADPKD.
Related Concept Videos
Gallbladder
The gallbladder's anatomy consists of three regions: the fundus, body, and neck. Extending from the neck, the cystic duct joins...
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Endoscopic Procedures V: ERCP
Patient...

